Immunohisto-chemical evidence confirms PLIN2’s localization on hepatic LD surfaces in fatty liver, suggesting its direct involvement in NAFLD etiopathogenesis [37]. Here, PLIN2 is linked to metabolic dysfunction-associated steatotic liver disease.